Your browser doesn't support javascript.
loading
Phase 1 Safety and Immunogenicity Trial of Recombinant Lactococcus lactis Expressing Human Papillomavirus Type 16 E6 Oncoprotein Vaccine.
Taghinezhad-S, Sedigheh; Mohseni, Amir Hossein; Keyvani, Hossein; Razavi, Mohammad Reza.
Afiliación
  • Taghinezhad-S S; Department of Microbiology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
  • Mohseni AH; Department of Microbiology, Faculty of Basic Sciences, Science and Research Branch, Islamic Azad University, Tehran 1477893855, Iran.
  • Keyvani H; Department of Virology, Faculty of Medicine, Iran University of Medical Sciences, Tehran 1449614535, Iran.
  • Razavi MR; Department of Parasitology, Pasteur Institute of Iran, Tehran 1316943551, Iran.
Mol Ther Methods Clin Dev ; 15: 40-51, 2019 Dec 13.
Article en En | MEDLINE | ID: mdl-31649954
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2019 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Mol Ther Methods Clin Dev Año: 2019 Tipo del documento: Article País de afiliación: Irán